Jeddah Health Cluster Two signs cooperation agreement with Jamjoom Pharma to enhance healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies specializing in the pharmaceutical industry. This partnership aims to develop health services and raise the level of medical awareness in the Kingdom of Saudi Arabia.
The agreement focuses primarily on the exchange of expertise between the two parties to develop human capabilities in the health sector. Through this collaboration, both parties also seek to provide specialized training programs that contribute to improving the efficiency of medical personnel working in the cluster's facilities.
In addition to the training aspect, the agreement includes initiatives aimed at enhancing health awareness among members of the community. Jamjoom Pharma will support the awareness campaigns organized by the cluster, which will help disseminate knowledge about disease prevention and the importance of continuous healthcare.
This step comes within the framework of the Kingdom's ongoing efforts to achieve the goals of Saudi Vision 2030, which places the development of the health sector at the top of its priorities. Through these partnerships, Jeddah Health Cluster Two seeks to strengthen cooperation with the private sector to provide the best services to citizens and residents.
In conclusion, this agreement reflects the commitment of national institutions to joint work to improve the quality of life. This initiative is expected to contribute to fostering innovation in health services and providing more effective pharmaceutical and preventive solutions in the city of Jeddah and its surrounding areas.